Maja Galić

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning et al. · The Lancet · 2019 · 418 citations

Cluster Headache, Documented Failure, Clinical Trials +7

Secretory Antibodies Do Not Affect the Composition of the Bacterial Microbiota in the Terminal Ileum of 10-Week-Old Mice

Leanne Sait, Maja Galić, Richard A. Strugnell et al. · Applied and Environmental Microbiology · 2003 · 101 citations · Full text

PCR-generated artefact from 16S rRNA gene-specific primers

Catherine A. Osborne, Maja Galić, Parveen Sangwan et al. · FEMS Microbiology Letters · 2005 · 83 citations

Different Primers, Engineering, Genetics +14

Secretory antibodies reduce systemic antibody responses against the gastrointestinal commensal flora

Leanne Sait, Maja Galić, Jason D. Price et al. · International Immunology · 2007 · 83 citations

Systemic Antibody Responses, Dysbiosis, Allergy +15

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

Richard B. Lipton, Joshua M. Cohen, Maja Galić et al. · Headache The Journal of Head and Face Pain · 2021 · 52 citations · Full text